Literature DB >> 21870251

Approaches to detect PARP-1 activation in vivo, in situ, and in vitro.

Girish M Shah1, Febitha Kandan-Kulangara, Alicia Montoni, Rashmi G Shah, Julie Brind'amour, Momchild D Vodenicharov, El Bachir Affar.   

Abstract

An accurate and sensitive detection of catalytic activation of poly(ADP-ribose) polymerase-1 (PARP-1) is required to be performed in a wide variety of samples because this activity plays a role in various cellular responses to DNA damage ranging from DNA repair to cell death, as well as in housekeeping functions, such as transcription. Since PARP-1 gene is expressed constitutively, its activation cannot be surmised from increased expression of its mRNA or protein, but by demonstrating the consequences of its catalytic -reaction which results in consumption of the substrate nicotinamide adenine dinucleotide (NAD(+)) and formation of three products, namely, polymer of ADP-ribose (pADPr or PAR), nicotinamide, and protons. Here, we describe various approaches commonly used in our laboratory for detection of PARP-1 activation in vivo (cells, tissues, and tumors), in situ, and in vitro via assessment of formation of pADPr, depletion of the substrate NAD, or formation of protons resulting in rapid and reversible intracellular acidification. It is important to note that although some other members of the PARP family can carry out the same catalytic reaction, many of these assays largely reflect PARP-1 activation in a vast majority of the experimental circumstances and more specifically in DNA damage responses. However, if required, PARP-1-specific action should be confirmed by use of PARP-1 knockout or RNAi-mediated knockdown approaches.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21870251     DOI: 10.1007/978-1-61779-270-0_1

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  11 in total

1.  Metabolomic analysis of exercise effects in the POLG mitochondrial DNA mutator mouse brain.

Authors:  Joanne Clark-Matott; Ayesha Saleem; Ying Dai; Yevgeniya Shurubor; Xiaoxing Ma; Adeel Safdar; Myron Flint Beal; Mark Tarnopolsky; David K Simon
Journal:  Neurobiol Aging       Date:  2015-07-21       Impact factor: 4.673

2.  Deubiquitinating enzymes and the proteasome regulate preferential sets of ubiquitin substrates.

Authors:  Fredrik Trulsson; Vyacheslav Akimov; Mihaela Robu; Nila van Overbeek; David Aureliano Pérez Berrocal; Rashmi G Shah; Jürgen Cox; Girish M Shah; Blagoy Blagoev; Alfred C O Vertegaal
Journal:  Nat Commun       Date:  2022-05-18       Impact factor: 17.694

3.  Role of poly(ADP-ribose) polymerase-1 in the removal of UV-induced DNA lesions by nucleotide excision repair.

Authors:  Mihaela Robu; Rashmi G Shah; Nancy Petitclerc; Julie Brind'Amour; Febitha Kandan-Kulangara; Girish M Shah
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-14       Impact factor: 11.205

4.  Quantification of cellular poly(ADP-ribosyl)ation by stable isotope dilution mass spectrometry reveals tissue- and drug-dependent stress response dynamics.

Authors:  Rita Martello; Aswin Mangerich; Sabine Sass; Peter C Dedon; Alexander Bürkle
Journal:  ACS Chem Biol       Date:  2013-05-13       Impact factor: 5.100

5.  Characterization of the interactions of PARP-1 with UV-damaged DNA in vivo and in vitro.

Authors:  Nupur K Purohit; Mihaela Robu; Rashmi G Shah; Nicholas E Geacintov; Girish M Shah
Journal:  Sci Rep       Date:  2016-01-12       Impact factor: 4.379

6.  XPC-PARP complexes engage the chromatin remodeler ALC1 to catalyze global genome DNA damage repair.

Authors:  Charlotte Blessing; Katja Apelt; Diana van den Heuvel; Claudia Gonzalez-Leal; Magdalena B Rother; Melanie van der Woude; Román González-Prieto; Adi Yifrach; Avital Parnas; Rashmi G Shah; Tia Tyrsett Kuo; Daphne E C Boer; Jin Cai; Angela Kragten; Hyun-Suk Kim; Orlando D Schärer; Alfred C O Vertegaal; Girish M Shah; Sheera Adar; Hannes Lans; Haico van Attikum; Andreas G Ladurner; Martijn S Luijsterburg
Journal:  Nat Commun       Date:  2022-08-13       Impact factor: 17.694

7.  Resistance to PARP-Inhibitors in Cancer Therapy.

Authors:  Alicia Montoni; Mihaela Robu; Emilie Pouliot; Girish M Shah
Journal:  Front Pharmacol       Date:  2013-02-27       Impact factor: 5.810

8.  Proteome-wide identification of the endogenous ADP-ribosylome of mammalian cells and tissue.

Authors:  Rita Martello; Mario Leutert; Stephanie Jungmichel; Vera Bilan; Sara C Larsen; Clifford Young; Michael O Hottiger; Michael L Nielsen
Journal:  Nat Commun       Date:  2016-09-30       Impact factor: 14.919

9.  Cumulative defects in DNA repair pathways drive the PARP inhibitor response in high-grade serous epithelial ovarian cancer cell lines.

Authors:  Hubert Fleury; Euridice Carmona; Vincent G Morin; Liliane Meunier; Jean-Yves Masson; Patricia N Tonin; Diane Provencher; Anne-Marie Mes-Masson
Journal:  Oncotarget       Date:  2017-06-20

10.  Loss of ZBTB24 impairs nonhomologous end-joining and class-switch recombination in patients with ICF syndrome.

Authors:  Angela Helfricht; Peter E Thijssen; Magdalena B Rother; Rashmi G Shah; Likun Du; Sanami Takada; Mélanie Rogier; Jacques Moritz; Hanna IJspeert; Chantal Stoepker; Monique M van Ostaijen-Ten Dam; Vincent Heyer; Martijn S Luijsterburg; Anton de Groot; Rianca Jak; Gwendolynn Grootaers; Jun Wang; Pooja Rao; Alfred C O Vertegaal; Maarten J D van Tol; Qiang Pan-Hammarström; Bernardo Reina-San-Martin; Girish M Shah; Mirjam van der Burg; Silvère M van der Maarel; Haico van Attikum
Journal:  J Exp Med       Date:  2020-11-02       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.